01—Abstract
Summary
Summary of the 10-K filed March 1, 2007. Cited figures are marked; the original filing is the authoritative source.
IDEX Corporation's 2006 Form 10-K reports record results across its four reporting segments, which were reorganized in 2006 from three to four: Fluid & Metering Technologies, Health & Science Technologies, Dispensing Equipment, and Fire & Safety/Diversified Products.
Net sales rose to $1,154.9 milliona in 2006 from $1,011.3 million in 2005, with base business sales up 9% and acquisitions contributing 5%. Operating income increased to $217.2 million (18.8% of sales), income from continuing operations rose 23% to $133.7 million, and net income increased 34% to $146.7 million, or $2.72 diluted EPS. New orders totaled $1,184.5 million, up 16%.
Growth was supported by five 2006 acquisitions (Airshore, JUN-AIR, Eastern Plastics, Banjo and Toptech) and the sale of the Lubriquip business, which produced a $16.7 millionb after-tax gain. Halox was classified as a discontinued operation and is being marketed for sale. Total borrowings rose to $362.0 million at year-end, and the company reported compliance with its two financial covenants.
Goodwill and intangible assets totaled $912.6 millionc and $171.4 million, respectively, and management concluded no impairment existed. Key risks cited include international exposure (45% of 2006 sales outside the U.S.), reliance on acquisitions for growth, competitive pressure, and exposure to euro and British pound currency movements.
The asbestos-related lawsuits named against IDEX and five subsidiaries are, per management, not expected to have a material adverse effect. The filing also notes that the $150.0 milliond of 6.875% Senior Notes mature February 15, 2008, and that the company was evaluating its options for repaying them, including potential use of its credit facility.
02—Key points
Key Highlights
- Net sales of $1,154.9 million in 2006, up 14% from $1,011.3 million in 2005; base business sales rose 9%
- Operating income of $217.2 million, an 18.8% operating margin, up 90 basis points from 17.9% in 2005
- Net income of $146.7 million ($2.72 diluted EPS), up 34%; income from continuing operations of $133.7 million, up 23%
- New orders of $1,184.5 million, up 16% from the prior year, with base business orders up 10%
- Five acquisitions in 2006 (Airshore, JUN-AIR, Eastern Plastics, Banjo, Toptech) plus the Lubriquip divestiture with a $16.7 million after-tax gain
- Total borrowings of $362.0 million at December 31, 2006, with $194.0 million outstanding under the $600.0 million Credit Facility; $150.0 million of 6.875% Senior Notes due February 15, 2008
- Post-period acquisition of Faure Herman SA, a flow meter provider with annual revenues of approximately $22 million
03—Questions
Frequently Asked Questions
What drove IDEX's earnings growth in 2006?
Higher sales, improved gross margin (41.3% of sales, up 40 basis points) and SG&A leverage drove operating income up $36.2 million, or 20%, to $217.2 million. The filing attributes the gross margin gain primarily to strategic sourcing and operational excellence initiatives. Acquisitions and base business growth both contributed to sales growth.
How did each reporting segment perform in 2006?
Fluid & Metering Technologies had sales of $435.5 million and operating income of $89.9 million (20.6% margin). Health & Science Technologies had sales of $304.9 million, up 29%, and operating income of $58.2 million. Dispensing Equipment had sales of $159.8 million, up 1%, and operating income of $38.0 million. Fire & Safety/Diversified Products had sales of $260.1 million and operating income of $62.7 million (24.1% margin).
What is IDEX's debt position and near-term refinancing need?
Total borrowings were $362.0 million at year-end 2006, about 59% of which floats with market rates. The $150.0 million Senior Notes mature February 15, 2008, and the company stated it was evaluating its options, including potential use of its Credit Facility. The company reported compliance with its minimum interest coverage (3.0 to 1) and maximum leverage (3.25 to 1) covenants.
What are the main risks identified in the filing?
The filing cites exposure to international operations (45% of 2006 sales outside the U.S.), dependence on acquisitions and their integration, competitive pricing pressure, raw material availability, currency fluctuations mainly involving the euro and British pound, interest rate increases on floating-rate debt, and potential goodwill impairment given $912.6 million of goodwill. Asbestos-related claims are described as not expected to have a material adverse effect.
04—Continue